Tara O. Henderson to Male
This is a "connection" page, showing publications Tara O. Henderson has written about Male.
Connection Strength
0.752
-
Adverse Childhood Experiences, Resilience, and Cardiovascular Disease in Adult Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2024 Aug 01; 33(8):1132-1136.
Score: 0.048
-
The Association of Neighborhood Characteristics and Frailty in Childhood Cancer Survivors: A Report from the St. Jude Lifetime Cohort Study. Cancer Epidemiol Biomarkers Prev. 2023 08 01; 32(8):1021-1029.
Score: 0.045
-
Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor. Cancer. 2022 01 15; 128(2):373-382.
Score: 0.040
-
Substance use behaviors in adolescent and young adult cancer patients: Associations with mental and physical health. Psychooncology. 2020 06; 29(6):1068-1076.
Score: 0.036
-
Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study. Lancet Oncol. 2020 03; 21(3):421-435.
Score: 0.036
-
Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes. Br J Haematol. 2018 07; 182(2):212-221.
Score: 0.031
-
Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis. Cancer. 2018 01 01; 124(1):136-144.
Score: 0.030
-
Enhancing Health Care of Survivors of Childhood Cancer With Tailored Education. J Clin Oncol. 2015 Nov 20; 33(33):3849-50.
Score: 0.026
-
General internists' preferences and knowledge about the care of adult survivors of childhood cancer: a cross-sectional survey. Ann Intern Med. 2014 Jan 07; 160(1):11-7.
Score: 0.023
-
Accelerated aging among cancer survivors: from pediatrics to geriatrics. Am Soc Clin Oncol Educ Book. 2014; e423-30.
Score: 0.023
-
Challenges in interpreting the evidence for genetic predictors of ototoxicity. Clin Pharmacol Ther. 2013 Dec; 94(6):631-5.
Score: 0.023
-
Family physician preferences and knowledge gaps regarding the care of adolescent and young adult survivors of childhood cancer. J Cancer Surviv. 2013 Sep; 7(3):275-82.
Score: 0.022
-
Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study. Int J Radiat Oncol Biol Phys. 2012 Sep 01; 84(1):224-30.
Score: 0.021
-
Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group study. J Clin Oncol. 2011 Jan 01; 29(1):76-82.
Score: 0.019
-
Childhood cancer survivors: transition to adult-focused risk-based care. Pediatrics. 2010 Jul; 126(1):129-36.
Score: 0.018
-
Physician preferences and knowledge gaps regarding the care of childhood cancer survivors: a mailed survey of pediatric oncologists. J Clin Oncol. 2010 Feb 10; 28(5):878-83.
Score: 0.018
-
Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2007 Feb 21; 99(4):300-8.
Score: 0.014
-
Late subsequent leukemia after childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS). Cancer Med. 2024 Oct; 13(20):e70086.
Score: 0.012
-
Health insurance among survivors of childhood cancer following Affordable Care Act implementation. J Natl Cancer Inst. 2024 Sep 01; 116(9):1466-1478.
Score: 0.012
-
Longitudinal Health-Related Quality of Life Among Patients With High-Risk Pediatric Hodgkin Lymphoma Treated on the Children's Oncology Group AHOD 1331 Study. J Clin Oncol. 2024 Oct; 42(28):3330-3338.
Score: 0.012
-
Impact of risk-based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2024 Jun 07; 116(6):885-894.
Score: 0.012
-
Development and validation of a population-based anatomical colorectal model for radiation dosimetry in late effects studies of survivors of childhood cancer. Radiother Oncol. 2022 11; 176:118-126.
Score: 0.011
-
Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children's oncology group trials. Lancet Haematol. 2022 Jan; 9(1):e49-e57.
Score: 0.010
-
Poverty and Targeted Immunotherapy: Survival in Children's Oncology Group Clinical Trials for High-Risk Neuroblastoma. J Natl Cancer Inst. 2021 03 01; 113(3):282-291.
Score: 0.010
-
Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2021 07 10; 39(20):2266-2275.
Score: 0.010
-
An evaluation of PlayStreets in the South Side neighborhood of Columbus, Ohio. Perspect Public Health. 2021 Mar; 141(2):97-101.
Score: 0.010
-
Adherence to Surveillance for Second Malignant Neoplasms and Cardiac Dysfunction in Childhood Cancer Survivors: A Childhood Cancer Survivor Study. J Clin Oncol. 2020 05 20; 38(15):1711-1722.
Score: 0.009
-
Comparison of Radiation Dose Reconstruction Methods to Investigate Late Adverse Effects of Radiotherapy for Childhood Cancer: A Report from the Childhood Cancer Survivor Study. Radiat Res. 2020 02; 193(2):95-106.
Score: 0.009
-
Survival by Race and Ethnicity in Pediatric and Adolescent Patients With Hodgkin Lymphoma: A Children's Oncology Group Study. J Clin Oncol. 2019 11 10; 37(32):3009-3017.
Score: 0.009
-
Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline. J Clin Oncol. 2019 11 01; 37(31):2916-2946.
Score: 0.009
-
Mucosal-associated Lymphoid Tissue (MALT) Lymphoma in Association With Pediatric Primary Sjogren Syndrome: 2 Cases and Review. J Pediatr Hematol Oncol. 2019 Jul; 41(5):413-416.
Score: 0.009
-
Transitional care practices, services, and delivery in childhood cancer survivor programs: A survey study of U.S. survivorship providers. Pediatr Blood Cancer. 2019 08; 66(8):e27793.
Score: 0.008
-
Patient-Reported Health-Related Quality-of-Life Assessment at the Point-of-Care with Adolescents and Young Adults with Cancer. J Adolesc Young Adult Oncol. 2018 02; 7(1):97-102.
Score: 0.008
-
Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015. JAMA. 2017 02 28; 317(8):814-824.
Score: 0.007
-
Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study. Cancer. 2017 Jul 01; 123(13):2551-2560.
Score: 0.007
-
Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project. Eur J Cancer. 2017 02; 72:177-185.
Score: 0.007
-
Effect of Temporal Changes in Therapeutic Exposure on Self-reported Health Status in Childhood Cancer Survivors. Ann Intern Med. 2017 Jan 17; 166(2):89-98.
Score: 0.007
-
Cognitive, behaviour, and academic functioning in adolescent and young adult survivors of childhood acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study. Lancet Psychiatry. 2016 Oct; 3(10):965-972.
Score: 0.007
-
Factors associated with increasing campylobacteriosis incidence in Michigan, 2004-2013. Epidemiol Infect. 2016 11; 144(15):3316-3325.
Score: 0.007
-
Radiation-Related New Primary Solid Cancers in the Childhood Cancer Survivor Study: Comparative Radiation Dose Response and Modification of Treatment Effects. Int J Radiat Oncol Biol Phys. 2016 Mar 15; 94(4):800-7.
Score: 0.007
-
Increasing incidence of non-O157 Shiga toxin-producing Escherichia coli (STEC) in Michigan and association with clinical illness. Epidemiol Infect. 2016 05; 144(7):1394-405.
Score: 0.007
-
Predictors of colorectal cancer surveillance among survivors of childhood cancer treated with radiation: a report from the Childhood Cancer Survivor Study. Cancer. 2015 Jun 01; 121(11):1856-63.
Score: 0.006
-
Identifying Predictors of Longitudinal Decline in the Level of Medical Care Received by Adult Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study. Health Serv Res. 2015 Aug; 50(4):1021-42.
Score: 0.006
-
Health behaviors of minority childhood cancer survivors. Cancer. 2015 May 15; 121(10):1671-80.
Score: 0.006
-
Second malignancies in patients with neuroblastoma: the effects of risk-based therapy. Pediatr Blood Cancer. 2015 Jan; 62(1):128-33.
Score: 0.006
-
Effect of cocoa and green tea on biomarkers of glucose regulation, oxidative stress, inflammation and hemostasis in obese adults at risk for insulin resistance. Eur J Clin Nutr. 2012 Oct; 66(10):1153-9.
Score: 0.005
-
Angiotensin and adrenoceptors in the hemodynamic response to aortic cross-clamping. Arch Surg. 1992 Apr; 127(4):438-41.
Score: 0.005
-
Physician preferences and knowledge regarding the care of childhood cancer survivors in Japan: a mailed survey of the Japanese Society of Pediatric Oncology. Jpn J Clin Oncol. 2012 Jun; 42(6):513-21.
Score: 0.005
-
Screening and surveillance for second malignant neoplasms in adult survivors of childhood cancer: a report from the childhood cancer survivor study. Ann Intern Med. 2010 Oct 05; 153(7):442-51.
Score: 0.005
-
The prevalence and causes of visual impairment in indigenous Australians within central Australia: the Central Australian Ocular Health Study. Br J Ophthalmol. 2010 Sep; 94(9):1140-4.
Score: 0.005
-
Health behaviors, medical care, and interventions to promote healthy living in the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009 May 10; 27(14):2363-73.
Score: 0.004
-
Suppression of bone density loss and bone turnover in patients with hormone-sensitive prostate cancer and receiving zoledronic acid. BJU Int. 2007 Jul; 100(1):70-5.
Score: 0.004
-
Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition. Clin Nutr. 2005 Oct; 24(5):839-47.
Score: 0.003
-
Trends and geographic variations in hospital admissions for asthma in Victoria. Opportunities for targeted interventions. Aust Fam Physician. 2003 Apr; 32(4):286-8.
Score: 0.003
-
Topical metronidazole for severe and recalcitrant rosacea: a prospective open trial. Cutis. 1989 Mar; 43(3):283-6.
Score: 0.001